Latest news with #HopeLodge
Yahoo
25-06-2025
- Health
- Yahoo
La Roche-Posay Becomes the Official Skincare Sponsor of the American Cancer Society's Hope Lodge Program
New national collaboration expands skincare support for cancer patients and caregivers NEW YORK, June 24, 2025 /PRNewswire/ -- La Roche-Posay, a leader in dermatological skincare trusted by over 100,000 dermatologists worldwide, is proud to announce its new role as the Official Skincare Sponsor of the American Cancer Society Hope Lodge program. This national-level sponsorship marks a deepened commitment to supporting people with cancer and their caregivers, expanding upon years of oncology-focused initiatives across the brand. HOPE LODGE SUPPORT EXPANSION As the exclusive National Skincare Sponsor, La Roche-Posay will now extend its support to all 31 Hope Lodge locations across the United States, which offer cancer patients and caregivers a free place to stay while undergoing treatment away from home. Through this collaboration, La Roche-Posay will fund over 5,000 nights of free lodging in 2025, helping to reduce the financial burden of cancer care and providing critical moments of rest and relief for people in treatment and their families. In addition, guests staying at Hope Lodge communities will receive specially curated skincare kits from La Roche-Posay, featuring products clinically tested for safety during cancer treatments**, including cleansers, moisturizers, and balms that can help manage some treatment-related skin side effects. "The American Cancer Society is committed to removing the emotional, physical, and financial burdens that many people with cancer must face when they travel away from home for treatment," said Tamara Fernandez, vice president, Hope Lodge for the American Cancer. "Thanks to the generosity of LaRoche-Posay, Hope Lodge guests can focus on what's important – getting well and feeling stronger during and after treatment." SUPPORTING SKIN THROUGH CANCER More than 80% of cancer patients experience skin-related side effects during treatment. La Roche-Posay's dermatologist-tested formulas are specifically designed for sensitive and irritated skin, offering soothing and restorative care that can help people feel more comfortable during cancer treatment. "La Roche-Posay dedicates itself to enhancing the well-being of individuals facing adverse skin conditions. In line with this commitment, we're honored to work collaborate with the American Cancer Society as the Official Skincare Sponsor of the Hope Lodge® program to offer support to people with cancer and their caregivers during treatment. Recognizing that skincare guidance is often overlooked during this challenging time, we aim to collaborate with the American Cancer Society and individual Hope Lodge® communities to provide resources and solutions that address the skin-related side effects of cancer treatment, ultimately improving the quality of life for patients and their families throughout their cancer journey." – Rachelle Mladjenovic, GM, La Roche-Posay, USA This initiative is a continuation of La Roche-Posay's longstanding global oncology mission, including its Thermal Dermatology Center in France, where over 7,500 patients per year — nearly half of whom are cancer survivors — receive supportive skin therapy during or after treatment. ABOUT LA ROCHE-POSAYRecommended by 100,000 dermatologists worldwide [1], La Roche-Posay's mission is to offer life-changing dermatological skincare. La Roche-Posay offers a unique range of daily skincare developed for every skin type to address various skin concerns and complement prescription treatments. At the center of the brand is the exclusive selenium-rich La Roche-Posay Thermal Spring Water, a core ingredient in its skincare formulas known for its soothing and antioxidant properties that is sourced from its Thermal Center in France, the first Dermatology Center in Europe. The products are developed using a strict safety and formulation charter with a minimal number of ingredients and are formulated at optimal concentrations. Additionally, La Roche-Posay products undergo stringent clinical testing for efficacy and safety with over 750+ studies and 25 years of extensive research, even on sensitive skin. For additional information about La Roche-Posay, visit and follow La Roche-Posay USA on Facebook, Instagram, and TikTok. Contact: LaRochePosa@ View original content to download multimedia: SOURCE La Roche-Posay Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
09-05-2025
- Health
- Yahoo
Ribbon-cutting held for newly renovated Hope Lodge
CHARLESTON, S.C. (WCBD) – The American Cancer Society held a ribbon-cutting and dedication ceremony Friday at Charleston's newly renovated Hope Lodge. The facility, now officially named the Richard M. Schulze Family Foundation Hope Lodge, offers free lodging to cancer patients and their caregivers traveling to the Charleston area for treatment. In 2024 alone, the Hope Lodge provided nearly 10,000 free nights of stay, saving patients and their families more than $1.3 million in lodging costs. Friday's ceremony celebrated not only the renovation but also the lodge's ongoing mission to ease the burden of care. 'At the American Cancer Society, one of the things I've really been talking to the staff about is the fact that every day when we get up, our goal is to ensure that we are looking at everybody – looking at their human condition, looking at the things they are going through – with one thing in mind: that we want to make sure we amplify their humanity. Every single day, in every small way,' said Wayne Frederick, interim CEO, American Cancer Society. The Charleston Hope Lodge is one of 31 facilities across the U.S. and Puerto Rico offering patients a home away from home during one of the most difficult times in their lives. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Business Wire
28-04-2025
- Health
- Business Wire
Tangle Teezer Partners With the American Cancer Society to Launch 'Brush with Hope'
NEW YORK--(BUSINESS WIRE)-- Tangle Teezer, a premium detangling hair care company with patented teeth technology, announced today its official partnership with the American Cancer Society (ACS) to launch 'Brush with Hope.' The partnership spans the entire brand and product range, including the newly launched Extra Gentle Ultimate Detangler ($15.99), created specifically with those who struggle with thinning hair, hair fall, and scalp sensitivity in mind. The ACS has data that shows one in two men and one in three women in the U.S. will develop cancer during their lifetime. Tangle Teezer's partnership with ACS aims to help those diagnosed with cancer feel stronger and more confident in their hair care routine. They will also donate $100,000 which will go toward cancer research, expanding access to care, promoting screenings, and tackling disparities. Year-round efforts include volunteer days for U.S. team members and a special Hope Lodge event with a Tangle Teezer stylist ambassador. 'At Tangle Teezer, we know how personal one's relationship with their hair is,' says James Vowles, CEO of Tangle Teezer. 'We're honored to have partnered with American Cancer Society to help those experiencing thinning hair, hair fall, and scalp sensitivity to feel stronger and more confident in their hair care routine to help make a difference in the lives of those facing cancer. With the American Cancer Society, we're helping people feel stronger, more confident, and in control of their hair care during and after treatment.' 'It's important for cancer survivors to continue to feel like themselves during and after treatment,' said Chloe Lipman, vice president of development, American Cancer Society. 'We are excited to partner with Tangle Teezer and thankful for the collaboration which supports our mission and gives survivors confidence for their long-term well-being during and after cancer.' The ACS is dedicated to supporting those affected by cancer at every stage, from treatment to recovery, while the Tangle Teezer product assortment brings a range of tools designed to nurture and protect your hair throughout any stage of your hair journey. The new Extra Gentle Ultimate Detangler takes the brand's patented two-tiered technology to the next level, resulting in 77% 1 less hair fall and breakage when compared to a lab-standard brush. The wider-spaced teeth on the side of the brush minimize hair tension and give easy gliding. It is available at Ulta and online, as well as on Amazon, coming this summer. ______________________ 1 219 U.K. and U.S. female respondents after two weeks (2025) To learn more about Tangle Teezer and American Cancer Society's partnership, please visit For more information on Tangle Teezer, visit About Tangle Teezer Launched in 2007 as the world's first retail-anchored and professional detangling tool, Tangle Teezer is a British company that designs an award-winning range and unique patented range of brushes that allow customers to better manage long-term hair health with less damage and breakage. The first and signature product, a detangling hairbrush dubbed "The Original" eventually achieved cult popularity and received the Queen's Award for Innovation in 2012, and International Trade in 2014, as well as reaching the Sunday Times Fast Track 100 in 2013 and 2016. Today, Tangle Teezer is sold in 70 international markets. About American Cancer Society The American Cancer Society is a leading cancer-fighting organization with a vision to end cancer as we know it, for everyone. For more than 110 years, we have been improving the lives of people with cancer and their families as the only organization combating cancer through advocacy, research, and patient support. We are committed to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer. To learn more, visit or call our 24/7 helpline at 1-800-227-2345. Connect with us on Facebook, X, and Instagram.
Associated Press
25-02-2025
- Health
- Associated Press
Aflac and the American Cancer Society Team Up to encourage proactive health care and early detection
Teams to focus on preventive wellness by addressing physical, emotional and financial toxicity related to a cancer diagnosis COLUMBUS, Ga., Feb. 25, 2025 /PRNewswire/ -- Aflac Incorporated (Aflac), the leading provider of cancer insurance in the United States and Japan, is teaming up with the American Cancer Society (ACS), the leading cancer-fighting organization with a vision of ending cancer as we know it — for everyone. Together, they will shine a light on the ways early cancer detection can support individuals as they navigate the physical, emotional and financial challenges associated with the disease, particularly as data from the most recent (2024) Aflac Wellness Matters Survey found that 77% of Americans delay important health checkups,1 and 60% admit to avoiding important health and cancer screenings altogether,2 with millennials leading the pack. Throughout the collaboration, ACS and Aflac will work together to empower employees to take proactive steps in managing their health to enhance workforce well-being and assist in mitigating health care costs. This addresses key findings in the 2024-2025 Aflac WorkForces report that show 70% of employees experience at least some anxiety about a serious medical diagnosis,3 and 51% of Americans are unable to pay $1,000 out of pocket in the event of an unexpected illness or injury.4 Aligning with Aflac's core mission to provide benefits to policyholders before, during and after a cancer diagnosis, ACS programs and services will be shared, particularly benefitting those who have experienced a cancer diagnosis and are facing potential financial and logistical challenges. These include the ACS's Road to Recovery® program, which offers free rides to cancer-related medical appointments, and information on Hope Lodge®, a free patient lodging program for cancer patients seeking treatment outside of their community. 'As the leading provider and pioneer of cancer insurance sales in the United States, and with a 70-year record of providing valuable benefits and service to our customers, we know that early detection can help lead to better physical, emotional and financial outcomes,' Aflac Incorporated President Virgil Miller said. 'Aflac and the American Cancer Society are closely aligned on this mission to achieve better health outcomes and mitigate the financial toxicity of a major health event. We are pleased to join them to better serve families facing the challenges of a cancer diagnosis.' The collaboration will enable ACS to bring awareness to its Employee Toolkit efforts, including a new webpage that will provide on-demand access for employers to valuable cancer prevention-related content. Aflac associates will be able to share these tools with clients across the nation to provide for their employees. Each toolkit will include helpful information such as cancer screening guidelines, with facts and educational materials for individuals who have already been diagnosed with cancer. 'We're pleased to be working with Aflac in this mutual effort to help deliver greater access to our services and programs to those who need it the most,' said Dr. Arif Kamal, chief patient officer at the American Cancer Society. 'Cancer can't be fought alone. It takes a great deal of community support and access to resources to overcome the obstacles that many cancer patients face every day.' As an added level of commitment, Miller will initiate the first CEOs Against Cancer chapter in Georgia, where Aflac and ACS are headquartered, joining a group of prominent CEOs across the nation. Miller will accept a two-year term as chair of the newly created organization and serve as a spokesperson for the chapter. In 2023, Aflac updated its signature cancer policy, enhancing benefits to address changes in the health care system as well as benefits related to outpatient care. The company also established a new system wherein policyholders calling to file a first-time cancer claim are provided the option to speak directly with a team of professionals specifically trained to handle these often-emotional claims. Learn more about this important work at ABOUT AFLAC INCORPORATED Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for nearly seven decades to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.5 In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance in terms of policies in force. The company takes pride in being there for its policyholders when they need us most, as well as being included in the World's Most Ethical Companies by Ethisphere for 18 consecutive years (2024) and Fortune's World's Most Admired Companies for 23 years (2024). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021 and has been included in the Dow Jones Sustainability North America Index (2024) for 11 years. To find out how to get help with expenses health insurance doesn't cover, get to know us at or Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at under 'Sustainability.' 2 2024 Wellness Matters Survey Overview, page 20 3 2024-2025 Aflac Workforces Report Executive Summary, page 52 4 2024-2025 Aflac Workforces Report Executive Summary, page 46
Yahoo
25-02-2025
- Health
- Yahoo
Aflac and the American Cancer Society Team Up to encourage proactive health care and early detection
Teams to focus on preventive wellness by addressing physical, emotional and financial toxicity related to a cancer diagnosis COLUMBUS, Ga., Feb. 25, 2025 /PRNewswire/ -- Aflac Incorporated (Aflac), the leading provider of cancer insurance in the United States and Japan, is teaming up with the American Cancer Society (ACS), the leading cancer-fighting organization with a vision of ending cancer as we know it — for everyone. Together, they will shine a light on the ways early cancer detection can support individuals as they navigate the physical, emotional and financial challenges associated with the disease, particularly as data from the most recent (2024) Aflac Wellness Matters Survey found that 77% of Americans delay important health checkups,1 and 60% admit to avoiding important health and cancer screenings altogether,2 with millennials leading the pack. Throughout the collaboration, ACS and Aflac will work together to empower employees to take proactive steps in managing their health to enhance workforce well-being and assist in mitigating health care costs. This addresses key findings in the 2024-2025 Aflac WorkForces report that show 70% of employees experience at least some anxiety about a serious medical diagnosis,3 and 51% of Americans are unable to pay $1,000 out of pocket in the event of an unexpected illness or injury.4 Aligning with Aflac's core mission to provide benefits to policyholders before, during and after a cancer diagnosis, ACS programs and services will be shared, particularly benefitting those who have experienced a cancer diagnosis and are facing potential financial and logistical challenges. These include the ACS's Road to Recovery® program, which offers free rides to cancer-related medical appointments, and information on Hope Lodge®, a free patient lodging program for cancer patients seeking treatment outside of their community. "As the leading provider and pioneer of cancer insurance sales in the United States, and with a 70-year record of providing valuable benefits and service to our customers, we know that early detection can help lead to better physical, emotional and financial outcomes," Aflac Incorporated President Virgil Miller said. "Aflac and the American Cancer Society are closely aligned on this mission to achieve better health outcomes and mitigate the financial toxicity of a major health event. We are pleased to join them to better serve families facing the challenges of a cancer diagnosis." The collaboration will enable ACS to bring awareness to its Employee Toolkit efforts, including a new webpage that will provide on-demand access for employers to valuable cancer prevention-related content. Aflac associates will be able to share these tools with clients across the nation to provide for their employees. Each toolkit will include helpful information such as cancer screening guidelines, with facts and educational materials for individuals who have already been diagnosed with cancer. "We're pleased to be working with Aflac in this mutual effort to help deliver greater access to our services and programs to those who need it the most," said Dr. Arif Kamal, chief patient officer at the American Cancer Society. "Cancer can't be fought alone. It takes a great deal of community support and access to resources to overcome the obstacles that many cancer patients face every day." As an added level of commitment, Miller will initiate the first CEOs Against Cancer chapter in Georgia, where Aflac and ACS are headquartered, joining a group of prominent CEOs across the nation. Miller will accept a two-year term as chair of the newly created organization and serve as a spokesperson for the chapter. In 2023, Aflac updated its signature cancer policy, enhancing benefits to address changes in the health care system as well as benefits related to outpatient care. The company also established a new system wherein policyholders calling to file a first-time cancer claim are provided the option to speak directly with a team of professionals specifically trained to handle these often-emotional claims. Learn more about this important work at ABOUT AFLAC INCORPORATEDAflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for nearly seven decades to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.5 In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance in terms of policies in force. The company takes pride in being there for its policyholders when they need us most, as well as being included in the World's Most Ethical Companies by Ethisphere for 18 consecutive years (2024) and Fortune's World's Most Admired Companies for 23 years (2024). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021 and has been included in the Dow Jones Sustainability North America Index (2024) for 11 years. To find out how to get help with expenses health insurance doesn't cover, get to know us at or Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at under "Sustainability." 1 2024 Wellness Matters Survey Overview, page 182 2024 Wellness Matters Survey Overview, page 203 2024-2025 Aflac Workforces Report Executive Summary, page 5242024-2025 Aflac Workforces Report Executive Summary, page 465 LIMRA 2023 U.S. Supplemental Health Insurance Total Market Report Media contact: Jon Sullivan, 706-763-4813 or jsullivan@ Analyst and investor contact: David A. Young, 706-596-3264, 800-235-2667 or dyoung@ Aflac | Aflac New York | WWHQ | 1932 Wynnton Road | Columbus, GA 31999 View original content to download multimedia: SOURCE Aflac Sign in to access your portfolio
